Switch Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 14, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $52,000,000
Company Info
- Founders
- Dee Datta, Ph.D.
- Company Description
- Switch Therapeutics is a biotech company that develops RNAi therapies.
- Market
- Healthcare
- Location
- San Francisco, CA, USA
- Coinvestors
- BOLD Capital Partners, Digitalis Ventures, Eli Lilly and Company, Insight Partners, Ono Venture Investment, UCB Ventures, Upfront Ventures